Theravance Biopharma, Inc.

{
  "main_header": {
    "sid": 1134408,
    "name": "Theravance Biopharma, Inc.",
    "stock_name": "Theravance Biopharma, Inc.",
    "full_name": "Theravance Biopharma, Inc.",
    "name_url": "stocks-analysis/theravance-biopharma-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "20.09",
    "chg": 0.1,
    "chgp": "0.5%",
    "dir": 1,
    "prev_price": "19.99",
    "mcapval": "1,032.20",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "KYG8807B1068",
    "curr_date": "Feb 04",
    "curr_time": "",
    "bse_nse_vol": "997.36 k",
    "exc_status": "Active",
    "traded_date": "Feb 04, 2026",
    "traded_date_str": "2026 02 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/theravance-biopharma-inc-1134408-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Theravance Biopharma Hits New 52-Week High of $18.96, Up 112.64%",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/theravance-biopharma-hits-new-52-week-high-of-1896-up-11264-3693004",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/TheravanceBioph_priceRelatedfactors_3693004.png",
        "date": "2025-11-12 16:14:00",
        "description": "Theravance Biopharma, Inc. achieved a new 52-week high of USD 18.96, reflecting strong performance in the pharmaceuticals sector. The company reported a 112.64% increase in stock performance over the past year and an 83.75% rise in net sales, supported by high institutional holdings and solid financial metrics."
      },
      {
        "title": "Theravance Biopharma Achieves Multibagger Status with 103.74% Stock Surge Over Past Year",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/theravance-biopharma-achieves-multibagger-status-with-10374-stock-surge-over-past-year-3692981",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/TheravanceBioph_multibagger_3692981.png",
        "date": "2025-11-12 15:26:56",
        "description": "Theravance Biopharma, Inc. has recently undergone a revision in its score, reflecting its impressive performance metrics and strong market position. The stock has outperformed the S&P 500 significantly over the past year and reported substantial growth in net sales and operating cash flow, indicating robust operational strength."
      }
    ],
    "total": 25,
    "sid": "1134408",
    "stock_news_url": "https://www.marketsmojo.com/news/theravance-biopharma-inc-1134408"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Theravance Biopharma Hits New 52-Week High of $18.96, Up 112.64%

2025-11-12 16:14:00

Theravance Biopharma, Inc. achieved a new 52-week high of USD 18.96, reflecting strong performance in the pharmaceuticals sector. The company reported a 112.64% increase in stock performance over the past year and an 83.75% rise in net sales, supported by high institutional holdings and solid financial metrics.

Read full news article

Theravance Biopharma Achieves Multibagger Status with 103.74% Stock Surge Over Past Year

2025-11-12 15:26:56

Theravance Biopharma, Inc. has recently undergone a revision in its score, reflecting its impressive performance metrics and strong market position. The stock has outperformed the S&P 500 significantly over the past year and reported substantial growth in net sales and operating cash flow, indicating robust operational strength.

Read full news article

View All News